Skip to content
Subscriber Only
Business
Prognosis

Moderna, J&J Make Case for Covid Boosters Ahead of FDA Panel

  • Companies recommend supplemental doses after six months
  • Meeting to close with presentation on mix-and-match boosters
Bloomberg business news
Moderna, J&J Make Booster Case Before FDA Panel
Updated on

Moderna Inc. and Johnson & Johnson said that data they’ve gathered supports the need for booster shots for their Covid-19 vaccines, ahead of a key regulatory meeting later this week.

A panel of scientific experts who advise the U.S. Food and Drug Administration on vaccines is scheduled to meet Thursday and Friday to weigh the evidence for booster doses for each of the two vaccines. The regulator has already authorized a booster for the Covid shot made by Pfizer Inc. and BioNTech SE for those 65 and older and other at-risk adults.